UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 9 | September 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 9
September-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2509416


Registration ID:
569685

Page Number

e136-e147

Share This Article


Jetir RMS

Title

Formulation and evaluation of Trelagliptin loaded fast-dissolving oral films

Abstract

The present study focuses on the preformulation, characterization, and development of fast-dissolving oral films of Trelagliptin, aiming to enhance patient compliance and achieve rapid drug release for the effective management of type 2 diabetes mellitus. Preformulation studies confirmed the drug’s identity, purity, and stability through organoleptic evaluation, solubility profiling, FTIR spectroscopy, loss on drying, and melting point analysis. Trelagliptin exhibited versatile solubility in both aqueous and organic solvents and showed excellent linearity (r² = 0.999) in UV spectrophotometric analysis at 276 nm. Nine formulations (F1–F9) of oral films were prepared using different polymers and evaluated for physicochemical and mechanical properties. All formulations demonstrated uniform appearance, consistent thickness, and satisfactory film characteristics. Among them, formulation F6 was identified as the optimized batch, exhibiting the shortest disintegration time (55±7 sec), highest drug release (97.65% in 10 min), maximum folding endurance (185±5), and excellent assay value (99.12±0.18%). Drug release from F6 followed first-order kinetics with non-Fickian diffusion, indicating a combination of diffusion and polymer relaxation mechanisms. Stability studies under accelerated conditions over three months confirmed the formulation’s robustness, with minimal changes in drug content and physical attributes. In conclusion, the optimized Trelagliptin fast-dissolving film (F6) demonstrated promising attributes such as rapid onset of action, high drug release, and improved patient convenience, offering a stable and effective alternative dosage form for type 2 diabetes treatment.

Key Words

Trelagliptin, Fast-dissolving oral films, Preformulation studies, Drug release kinetics, Non-Fickian diffusion, Type 2 diabetes mellitus

Cite This Article

"Formulation and evaluation of Trelagliptin loaded fast-dissolving oral films", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 9, page no.e136-e147, September-2025, Available :http://www.jetir.org/papers/JETIR2509416.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Formulation and evaluation of Trelagliptin loaded fast-dissolving oral films", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 9, page no. ppe136-e147, September-2025, Available at : http://www.jetir.org/papers/JETIR2509416.pdf

Publication Details

Published Paper ID: JETIR2509416
Registration ID: 569685
Published In: Volume 12 | Issue 9 | Year September-2025
DOI (Digital Object Identifier):
Page No: e136-e147
Country: -, -, India .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00028

Print This Page

Current Call For Paper

Jetir RMS